Quarterly report pursuant to Section 13 or 15(d)

Clinical Labs Asset Sale Agreement with Labcorp (Details)

v3.23.1
Clinical Labs Asset Sale Agreement with Labcorp (Details) - USD ($)
$ in Millions
2 Months Ended 9 Months Ended
Apr. 16, 2023
Apr. 30, 2023
Clinical Labs Asset Sale Agreement With Labcorp [Abstract]    
Cash $ 146  
Termination fee   $ 5
Reimbursement of buyer’s expenses   $ 5